Allogene Therapeutics
ALLO
ALLO
176 hedge funds and large institutions have $582M invested in Allogene Therapeutics in 2023 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 62 increasing their positions, 49 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
176
Holders Change
+8
Holders Change %
+4.76%
% of All Funds
2.82%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
29
Increased
62
Reduced
49
Closed
21
Calls
$333K
Puts
$2.13M
Net Calls
-$1.8M
Net Calls Change
-$2.02M
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$21.5M |
| 2 |
BBA
2
Baker Bros. Advisors
New York
|
$7.79M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$24.8M |
| 4 |
KCM
4
Kynam Capital Management
Princeton,
New Jersey
|
$7.39M |
| 5 |
5
Primecap Management
Pasadena,
California
|
$28.5M |
